International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: 10.5281/zenodo.1278258
Original Research Article
Comparative Analysis of Endo Venous Laser Ablation vs. Venous Stripping: Safety, Cost-Effectiveness and Efficiency in Varicose Vein Treatment
Published
Nov. 10, 2024
Abstract

This comparative study compared endovenous laser ablation (EVLA) and Venous stripping (anterograde and retrograde methods) for the treatment of varicose veins in a tertiary care hospital. Objective: Endovascular laser ablation (EVLA) is a minimally invasive procedure performed in the OPD or as a day care procedure with minimal blood loss and minimal invasion. The aim of this comparative study is to establish whether these technically improved outcomes are better than traditional venous stripping (anterograde and retrograde methods). Methods: Duration - 1 year (January 2023 to January 2024). Centre - Srinivas Institute of Medical Science & Research Centre, Mukka, Mangalore, Karnataka, India. Study Population: Patients presenting with varicose veins to General Surgery/ CTVS OPD. Study Design: Prospective study. This study compared postoperative patient comfort and the surgical outcome of endovenous laser ablation (EVLA) and high ligation venous stripping (Trendelenburg operation). Results: EVLA was found to be cost effective, OPD procedure. In our study, as compared between EVLA and venous stripping, study shows that EVLA is safer with minimal complications, early recovery, no recurrence and economically feasible. Conclusion: The findings of this study support the efficacy and safety of endovenous laser ablation (EVLA) as a superior alternative to high ligation venous stripping (Trendelenburg operation) for the treatment of varicose veins. These results advocate for the wider adoption of EVLA as the preferred treatment modality for varicose veins.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
730 Views
198 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved